Abstract

Being used in the treatment of advanced Parkinson’s disease, deep brain stimulation treatment is a method that requires close follow-up of the patient in the postoperative period. Surgical targets are predominantly subthalamic nucleus and sometimes globus pallidus internus, and also the thalamus ventral intermediolateral (VIM) nucleus for tremor-dominant Parkinson’s disease patients. Programming the stimulator differs for each target and the dopaminergic drugs are slowly reduced during the patient’s neuromodulation. Intrinsic and extrinsic side effects should be carefully tracked during the voltage adjustment in follow-ups and the patient should be controlled by optimal treatment.